Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, pharmacodynamics, and safety/tolerability of intrathecal RO7234292 (RG6042) in Huntington's disease patients has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• RG6042 (RO7234292) (RO7234292)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Huntingtons Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-10-03